Novocure Limited (NVCR) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Novocure Limited  (NASDAQ: NVCR)


Novocure Limited's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Novocure Limited's ROI in the second quarter of 2026?
Novocure Limited recorded a cumulative net loss of $-149 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -22.87%.

Within the Healthcare sector 32 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 921 to 3370.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 20.96 % -0.09 % -14.61 % -32.24 % -45.75 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 574 661 682 682 582
Return On Investment (TTM) -22.87 % -26.55 % -21.45 % -30.33 % -31.83 %
NVCR's Overall Ranking # 3370 # 921 # 2484 # 3344 # 233
Seq. Investment Change TTM -0.3 % 2.59 % 8.44 % 9.06 % -17.65 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -149 -173 -136 -178 -171

NVCR Company Profile >> Back to NVCR Roi Comparisons >> See Annual NVCR Return On Investment



Return On Investment NVCR's Ranking
Within: No.
Industry # 13
Sector # 33
Overall # 3370

Return On Investment Statistics
High Average Low
4.76 %
-15.47 %
-39.54 %
(Sep 30 2020)   (Jun 30 2017)



  News about Novocure Limited Return on Investment ROI

Novocure's New Chief Medical Officer Joins Forces to Tackle Financial Headwinds

January 4, 2024


Novocure, a leading global oncology company, has recently named Dr. Nicolas Leupin as their new Chief Medical Officer (CMO). Dr. Leupin s appointment comes at a crucial time for the company as it seeks to navigate both medical and financial challenges. With a strong background in the biotechnology and pharmaceutical industries, as well as extensive experience as a medical oncologist and educator, Dr. Leupin is well-positioned to steer Novocure towards success.
In his role as CMO, Dr. Leupin will be responsible for overseeing medical affairs, medical safety, and clinical development operations. This will be vital as Novocure aims to advance its clinical programs and bring innovative oncology treatments to market. With his proven track record of leadership and accomplishments, Dr. Leupin is expected to contribute significantly to the company s growth strategy.





Financial Statements
Novocure Limited's II. Quarter Investments $ 574 Millions NVCR's Balance sheet
Novocure Limited's II. Quarter Income $ -16 Millions Quarterly NVCR's Income Statement
NVCR's Income by Division See NVCR's Income by Division


NVCR Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 581 484 967 1,033 997
Y / Y Investment Growth 19.96 % -49.91 % -6.38 % 3.61 % 6.24 %
Net Income in Millions -136 -169 -207 -93 -58
Y / Y Net Income Growth - - - - -
Annual Return On Investment -23.44 % -34.81 % -21.41 % -8.96 % -5.85 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NVCR's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NVCR's Competitors
Subscribers only: Roi for Novocure Limited's Suppliers
Subscribers only: Return On Investment for NVCR's Customers

Other Ratios
NVCR's Roa NVCR's Inventory Turnover Ratio NVCR's Growth Rates NVCR's Dividend Statistics
NVCR's Profitability Ratios NVCR's Asset Turnover Ratio NVCR's Dividend Growth
NVCR's Roe NVCR's Valuation Ratios NVCR's Financial Strength Ratios NVCR's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T21:20:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.